Cipla's bitter pill for MNCs

Several eyebrows have been raised over the Cipla offer to supply anti- aids drugs at one-third the current price to developing countries like …

Evergreen Novartis

The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy

The Kani learning

How benefit-sharing between a research institute and the Kani tribe went awry

Cipla's audacious move

Why generics maker Cipla has asked government to revoke Novartis patent on respiratory ailment drug

Monsanto does it again

The biotech seed giant sues a farmer for planting unbranded commodity seeds bought in the open market for patent infringement

The natco-pfizer test

Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India

A cosmetic leap of faith

Industry ignores perils of using nanotechnology in beauty products

Gunning for green tech

US continues to target India over its intellectual property regime, especially in pharma, green tech sectors

Crazy GM patent system

The Brazilian lawsuit against Monsanto’s royalty on soybean seeds exposes the irrational way in which laws apply to GM crops

Righting the copywrong

Amending the Copyright Act to give directors, composers and musicians rights over their work has corrected a historic wrong but trouble is brewing

In Short

Patent hypocrisies of US

American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards

Any cheers for Doha pact?

The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …

No climate for cleantech

Most of the clean energy innovations are with just six rich countries and hardly any technology is coming to developing nations

Paan loses flavour

Iconic paan no more appeals to farmers, traders and common people. They say the contagious spread of chewing tobacco, especially gutkha, is fast …

A pre-emptive strike against Monsanto

American organic farmers are trying to ensure the biotech giant cannot sue them

Bringing Google to book

Google’s digital library project went too far, creating a monopoly over the heritage of books

The curious case of Ebola patents

The US government appears to have a cure and (almost) a vaccine for the deadly disease

Drug patents

Fruitful deliberations

Two global meetings chart a course for weeding out biopiracy

Patent issues delaying Ebola cure

Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine

What Durban did not discuss

IPRs are blocking access to mitigation and adaptation technologies. India offers a way out

New endosulfan ploy

Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global